ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

ClinicalTrials.gov ID: NCT06821061

Public ClinicalTrials.gov record NCT06821061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS

Study identification

NCT ID
NCT06821061
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
BioNTech SE
Industry
Enrollment
2,650 participants

Conditions and interventions

Interventions

  • Investigational COVID-19 Vaccine Biological
  • Investigational Influenza Vaccine Biological
  • Investigational Influenza and COVID-19 Combination Vaccine Combination Product
  • Licensed COVID-19 Vaccine Biological
  • Licensed Influenza Vaccine 1 Biological
  • Licensed Influenza Vaccine 2 Biological
  • Licensed Influenza Vaccine 3 Biological

Biological · Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 9, 2025
Primary completion
Dec 16, 2025
Completion
Dec 16, 2025
Last update posted
Jan 25, 2026

2025

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801
Orange County Research Center Lake Forest California 92630
Artemis Institute for Clinical Research Riverside California 92503
Artemis Institute for Clinical Research San Diego California 92103
Diablo Clinical Research, Inc. Walnut Creek California 94598
Clinical Research Consulting Milford Connecticut 06460
Alliance for Multispecialty Research, LLC Doral Florida 33172
Indago Research & Health Center, Inc Hialeah Florida 33012
Miami Dade Medical Research Institute, LLC Miami Florida 33176
Palm Springs Community Health Center Miami Lakes Florida 33014
Clinical Research Atlanta Stockbridge Georgia 30281
East-West Medical Research Institute Honolulu Hawaii 96814
Clinical Research Professionals Chesterfield Missouri 63005
Las Vegas Clinical Trials North Las Vegas Nevada 89030
Upstate Global Health Institute East Syracuse New York 13057
University of Rochester Medical Center Rochester New York 14642
Trial Management Associates - Wilmington - Floral Parkway Wilmington North Carolina 28403
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213
DM Clinical Research - Philadelphia Philadelphia Pennsylvania 19107
Coastal Carolina Research Center North Charleston South Carolina 29405
AMR Clinical Knoxville Tennessee 37909
AMR Clinical Knoxville Tennessee 37920
Clinical Research Associates Inc Nashville Tennessee 37203
Headlands Horizons, LLC dba Headlands Research-Brownsville Brownsville Texas 78526
DM Clinical Research- Cyfair Houston Texas 77065
SMS Clinical Research Mesquite Texas 75149
Dynamed Clinical Research, LP d/b/a DM Clinical Research Tomball Texas 77375
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121
Charlottesville Medical Research Charlottesville Virginia 22911
Kaiser Permanente Washington Health Research Institute (KPWHRI) Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06821061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06821061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →